[APLS] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -38.71%
YoY- -132.67%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 14,381 0 0 0 0 0 0 -
PBT -137,727 -183,659 -168,822 -50,574 -21,736 -9,051 -6,647 65.69%
Tax 1,208 5,719 3,933 340 267 -9,063 38 77.93%
NP -138,935 -183,659 -168,822 -50,574 -21,736 -9,051 -6,647 65.93%
Tax Rate - - - - - - - -
Total Cost 153,316 183,659 168,822 50,574 21,736 9,051 6,647 68.67%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -966.10 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -1.42 -2.32 -2.29 -0.87 -0.43 -0.50 -0.79 10.26%
EPS Diluted -1.42 -2.32 -2.29 -0.87 -0.43 -0.50 -0.79 10.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.